# Hari Pujar

> Hari Pujar is a Series A investor at Flagship Pioneering backing Biopharma and Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Flagship Pioneering](https://shizune.co/investors/profile/flagship-ventures)
- Location: Cambridge, United States
- Total investments: 1
- Last investment: Sep 2024
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/haripujar

Hari Pujar is a Series A investor at Flagship Pioneering in Cambridge focused on Biopharma and Biotechnology. Hari Pujar - Operating Partner @ Flagship Pioneering

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biopharma | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Mirai Bio | Mirai Bio has developed an open platform powered by AI to address the main drawbacks and manufacturing to develop the future of genetic medicine. | $50M | Series A | Sep 26, 2024 |  |

1 of 1 investments shown.

## About Flagship Pioneering

VC Fund · Cambridge, United States

Flagship Pioneering conceives, creates, resources, and grows first-in-category ventures to transform human health and sustainability. The company accelerates Flagship Pioneering’s advances in biology, engineering, medicine, energy, and beyond. The firm harnesses science and entrepreneurialism to envision alternative futures, beginning withseemingly unreasonable propositions and navigating to transformational outcomes through an evolutionary methodology.Flagship Pioneering combines innovative capacity, entrepreneurial leadership, and professional capital management in a single enterprise that systematically produces first-in-category companies.

5 contacts available at Flagship Pioneering.

| Name | Title | Profile |
| --- | --- | --- |
| Geoffrey von Maltzahn | General Partner | https://shizune.co/investors/profile/geoffrey-von-maltzahn |
| Hari Pujar | Operating Partner | https://shizune.co/investors/profile/hari-pujar |
| Thomas de Vlaam | Co-Founder FL86 | https://shizune.co/investors/profile/thomas-de-vlaam |
| Avak Kahvejian | General Partner | https://shizune.co/investors/profile/avak-kahvejian |
| Bill Johnson | Vice President of Finance | https://shizune.co/investors/profile/bill-johnson |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Hari Pujar invest in?

Hari Pujar invests primarily in Biopharma, Biotechnology and Pharmaceutical startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Hari Pujar last invest?

The most recent investment recorded for Hari Pujar closed in Sep 2024. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co